Jorge D. Brioni / Michael W. Decker (Hgg.)

Pharmacological Treatment of Alzheimer's Disease

Molecular and Neurobiological Foundations
Herausgegeben:Brioni, Jorge D.; Decker, Michael W.

• Gebundenes Buch

Produktbeschreibung

Geboten wird ein vollständiger, ausgewogener Überblick über die neuropharmakologischen Grundlagen von Therapeutika für die Alzheimer-Krankheit. Neueste Untersuchungen molekularer Strukturen und aktuelle klinische Daten werden mit der Verhaltens- und Erkenntnisforschung verknüpft und interpretiert.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 549
• Erscheinungstermin: 10. März 1997
• Englisch
• Abmessung: 240mm x 161mm x 35mm
• Gewicht: 992g
• ISBN-13: 9780471167587
• ISBN-10: 0471167584
• Artikelnr.: 13794611

Autorenporträt

Jorge D. Brioni and Michael W. Decker are the authors of Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations, published by Wiley.

Inhaltsangabe

I -
The Neurology of Cognition: Structure and Management of Multiple Memory
Systems in Alzheimer's Disease;
Interaction of Neuromodulatory Systems Regulating Memory Storage;
Monoamine and Acetylcholine Influences on Higher Cognitive Functions in
Nonhuman Primates with Relevance to the Treatment of Alzheimer's Disease;
Cortical Acetylcholine and Attention: Neuropharmacological and Cognitive
Principles Directing Treatment Strategies for Cognitive Disorders;
Neuropsychological Features of Alzheimer's Disease;
II -
Neuropathological Features of Alzheimer's Disease;
Normal Brain Ageing and Alzheimer's Disease Pathology;
Recent Developments in the Genetics of Alzheimer's Disease;
Neurofibrillary Tangles in Alzheimer's Disease: Clinical and Pathological
Implications;
Amyloid Cytoxicity and Alzheimer's Disease: Roles of Membrane Oxidation and
Perturbed Ion Homeostasis;
The Role of Apolipoprotein E in Neurobiology and the Pathogenesis of
Alzheimer's Disease;
Animal Models Relevant to Alzheimer's Disease;
III -
Alzheimer's Drug Discovery and Development: Alzheimer's Disease: An
International Public Health Problem- Clinical Goals, Strategies and
Outcomes;
Use of CSF-based Markers in the Diagnosis of Alzheimer's Disease;
Considerations for Clinical Trials in Alzheimer's Disease;
Cholinesterase Inhibition in the Treatment of Alzheimer's Disease: Further
Evaluation of the Clinical Effects of Tucrine;
Development of Muscarinic Agonists for the Symptomatic Treatment of
Alzheimer's Disease;
Neuronal Nicotinic Receptors: Potential Treatment for Alzheimer's Disease
with Novel Cholinergic Channel Activators;
Neurotrophic Factors: Potential for Therapeutic Intervention in Alzheimer's
Disease;
A Fundamental Role for Estrogens in Cognition and Neuroprotection;
Alzheimer's Disease: Prospects for Treatment in the Next Decade.